SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes

A brief, inexpensive screening test for sarcopenia would be helpful for clinicians and their patients. To screen for persons with sarcopenia, we developed a simple five‐item questionnaire (SARC‐F) based on cardinal features or consequences of sarcopenia.

[1]  J. Morley,et al.  Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans , 2013, Journal of cachexia, sarcopenia and muscle.

[2]  J. A. Serra-Rexach,et al.  Role of exercise on sarcopenia in the elderly. , 2013, European journal of physical and rehabilitation medicine.

[3]  M. Cesari,et al.  Sarcopenia: a novel clinical condition or still a matter for research? , 2012, Journal of the American Medical Directors Association.

[4]  L. Ferrucci,et al.  The Role of Energetic Cost in the Age‐Related Slowing of Gait Speed , 2012, Journal of the American Geriatrics Society.

[5]  M. Narici,et al.  Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review , 2012, Front. Physio..

[6]  J. Morley,et al.  A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans , 2012, The journal of nutrition, health & aging.

[7]  S. Cornish,et al.  Effect of nutritional interventions and resistance exercise on aging muscle mass and strength , 2012, Biogerontology.

[8]  G. Onder,et al.  Current and future pharmacologic treatment of sarcopenia. , 2011, Clinics in geriatric medicine.

[9]  Luigi Ferrucci,et al.  Sarcopenia with limited mobility: an international consensus. , 2011, Journal of the American Medical Directors Association.

[10]  Yu-fei Li,et al.  Sarcopenia , 2011 .

[11]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[12]  J. Morley.  Anabolic steroids and frailty. , 2010, Journal of the American Medical Directors Association.

[13]  L. Ferrucci,et al.  Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.

[14]  O. Johnell,et al.  BMD, clinical risk factors and their combination for hip fracture prevention , 2009, Osteoporosis International.

[15]  J. Miller,et al.  Development and validation of a short portable sarcopenia measure in the African American health project. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  J. E. Morley,et al.  Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives , 2008, The journal of nutrition, health & aging.

[17]  J. Miller,et al.  Adverse outcomes and correlates of change in the Short Physical Performance Battery over 36 months in the African American health project. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  R. Cooper,et al.  RE: Hirsch C, Anderson ML, Newman A, Kop W, Jackson S, Gottdiener J, et al, for the Cardiovascular Health Study Research Group. The association of race with frailty: The Cardiovascular Health Study. Ann Epidemiol. 2006;16:545-553. , 2007, Annals of epidemiology.

[19]  L. Fried,et al.  The association of race with frailty: the cardiovascular health study. , 2006, Annals of epidemiology.

[20]  J. Miller,et al.  Inner city, middle-aged African Americans have excess frank and subclinical disability. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  Ronenn Roubenoff,et al.  From the Chicago MeetingsSarcopenia , 2001 .

[22]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[23]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[24]  A. Aplogan,et al.  From the Centers for Disease Control and Prevention , 2015 .

[25]  R. Iniesta,et al.  Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. , 2013, Journal of the American Medical Directors Association.

[26]  J. Morley,et al.  Sarcopenia: The Target Population. , 2013, The Journal of frailty & aging.

[27]  Morley Je,et al.  Sarcopenia: The Target Population. , 2013 .

[28]  Susan Quine,et al.  Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial. , 2012, Journal of the American Medical Directors Association.

[29]  Todd M Manini,et al.  Dynapenia and aging: an update. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[30]  J. Kanis,et al.  FRAX® with and without Bone Mineral Density , 2011, Calcified Tissue International.

[31]  L. Lix,et al.  Fracture risk assessment without bone density measurement in routine clinical practice , 2011, Osteoporosis International.

[32]  I. Janssen,et al.  Dynapenic-obesity and physical function in older adults. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .